v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Real estate assets:    
Land [1] $ 581,751 $ 588,153
Buildings and improvements [1] 1,485,745 1,505,232
Real estate assets [1] 2,067,496 2,093,385
Accumulated depreciation [1] (314,093) (283,785)
Net investment in real estate assets [1] 1,753,403 1,809,600
Held-for-sale [1] 33,134 56,075
Developments in progress [1] 7,757 5,817
Net investment in real estate assets [1] 1,794,294 1,871,492
Cash and cash equivalents [1] 100,325 40,791
Restricted cash [1] 104,171 112,938
Available-for-sale securities - at fair value (amortized cost of $187,764 and $242,881 as of June 30, 2025 and December 31, 2024, respectively) [1] 187,662 243,148
Receivables:    
Tenant [1] 35,648 45,594
Other [1] 1,484 2,356
Investments in unconsolidated affiliates [1] 84,434 83,465
In-place leases, net [1] 148,572 186,561
Intangible lease assets and other assets [1] 146,417 160,846
Total assets [1] 2,603,007 2,747,191
LIABILITIES AND EQUITY    
Mortgage and other indebtedness, net 2,139,776 2,212,680
Accounts payable and accrued liabilities 185,718 221,647
Total liabilities [1] 2,325,494 2,434,327
Shareholders' equity:    
Common stock, $.001 par value, 200,000,000 shares authorized, 30,935,677 and 30,711,227 issued and outstanding as of June 30, 2025 and December 31, 2024, respectively (in each case, excluding 34 treasury shares) 31 31
Additional paid-in capital 699,150 694,566
Accumulated other comprehensive (loss) income (12) 782
Accumulated deficit (409,782) (371,833)
Total shareholders' equity 289,387 323,546
Noncontrolling interests (11,874) (10,682)
Total equity 277,513 312,864
Total liabilities, redeemable noncontrolling interests and equity $ 2,603,007 $ 2,747,191
[1] As of June 30, 2025, includes $167,278 of assets related to consolidated variable interest entities that can be used only to settle obligations of the consolidated variable interest entities and $210,970 of liabilities of consolidated variable interest entities for which creditors do not have recourse to the general credit of the Company. See Note 8.